Home > Healthcare > Biotechnology > Biotechnology R&D > Gene Synthesis Market
Gene Synthesis Market size accounted for USD 2.1 billion in 2022 and is estimated to grow at 18.7% between 2023 and 2032. Rising prevalence of genetic disorders and various chronic disease is expected to boost the market growth.
Rising burden of genetic disorders is expected to accelerate the adoption rate of gene synthesis and subsequent treatment, thereby augmenting the market growth. Additionally, the emergence of severe infectious disorders including COVID-19 and the Ebola pandemic has further resulted in the rising need for R&D across the globe. Hence, catering to such huge demand for newer treatment therapies, the companies are compelled to broaden their R&D capabilities with significant investments. However, rising government funding for R&D activities in the pharmaceutical industry affects is expected to propel the market revenue.
Gene synthesis is a laboratory technique that allows the creation of custom-made genes or DNA sequences. It involves the process of assembling nucleotides and the building blocks of DNA into a specific order to create a desired genetic sequence. This technique can be used to create completely new genes, modify existing genes, or synthesize large pieces of DNA from scratch. Further, gene synthesis comprises numerous applications in research, medicine, biotechnology, and other fields where genetic engineering is required.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Gene Synthesis Market Size in 2022: | USD 2.1 Billion |
Forecast Period: | 2023 to 2032 |
2032 Value Projection: | USD 11.7 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 383 |
Segments covered: | Method, Services, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|